MDxHealth Statistics
Total Valuation
MDxHealth has a market cap or net worth of $88.90 million. The enterprise value is $94.96 million.
Important Dates
The last earnings date was Wednesday, November 6, 2024, after market close.
| Earnings Date | Nov 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
MDxHealth has 47.29 million shares outstanding. The number of shares has increased by 20.44% in one year.
| Current Share Class | 47.29M |
| Shares Outstanding | 47.29M |
| Shares Change (YoY) | +20.44% |
| Shares Change (QoQ) | +1.92% |
| Owned by Insiders (%) | 8.76% |
| Owned by Institutions (%) | 31.46% |
| Float | 32.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.61 |
| Forward PS | 0.98 |
| PB Ratio | 3.09 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.12 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.54, with a Debt / Equity ratio of 3.26.
| Current Ratio | 1.54 |
| Quick Ratio | 1.41 |
| Debt / Equity | 3.26 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.96 |
Financial Efficiency
Return on equity (ROE) is -240.82% and return on invested capital (ROIC) is -24.67%.
| Return on Equity (ROE) | -240.82% |
| Return on Assets (ROA) | -11.02% |
| Return on Capital (ROIC) | -24.67% |
| Revenue Per Employee | $282,360 |
| Profits Per Employee | -$139,827 |
| Employee Count | 300 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 8.94 |
Taxes
In the past 12 months, MDxHealth has paid $335,000 in taxes.
| Income Tax | 335,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -36.49% in the last 52 weeks. The beta is -393,789.79, so MDxHealth's price volatility has been lower than the market average.
| Beta (5Y) | -393,789.79 |
| 52-Week Price Change | -36.49% |
| 50-Day Moving Average | 2.06 |
| 200-Day Moving Average | 2.64 |
| Relative Strength Index (RSI) | 47.88 |
| Average Volume (20 Days) | 162,953 |
Short Selling Information
| Short Interest | 14,236 |
| Short Previous Month | 29,361 |
| Short % of Shares Out | 0.04% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.15 |
Income Statement
In the last 12 months, MDxHealth had revenue of $84.71 million and -$41.95 million in losses. Loss per share was -$1.53.
| Revenue | 84.71M |
| Gross Profit | 52.30M |
| Operating Income | -25.83M |
| Pretax Income | -39.90M |
| Net Income | -41.95M |
| EBITDA | -20.11M |
| EBIT | -25.83M |
| Loss Per Share | -$1.53 |
Full Income StatementBalance Sheet
The company has $49.27 million in cash and $55.34 million in debt, giving a net cash position of -$6.06 million or -$0.13 per share.
| Cash & Cash Equivalents | 49.27M |
| Total Debt | 55.34M |
| Net Cash | -6.06M |
| Net Cash Per Share | -$0.13 |
| Equity (Book Value) | 16.99M |
| Book Value Per Share | 0.61 |
| Working Capital | 24.65M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$22.79 million and capital expenditures -$1.34 million, giving a free cash flow of -$24.13 million.
| Operating Cash Flow | -22.79M |
| Capital Expenditures | -1.34M |
| Free Cash Flow | -24.13M |
| FCF Per Share | -$0.51 |
Full Cash Flow StatementMargins
Gross margin is 61.74%, with operating and profit margins of -30.50% and -49.52%.
| Gross Margin | 61.74% |
| Operating Margin | -30.50% |
| Pretax Margin | -49.13% |
| Profit Margin | -49.52% |
| EBITDA Margin | -23.74% |
| EBIT Margin | -30.50% |
| FCF Margin | -33.09% |
Dividends & Yields
MDxHealth does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -20.44% |
| Shareholder Yield | -20.44% |
| Earnings Yield | -47.18% |
| FCF Yield | -27.14% |
Analyst Forecast
The average price target for MDxHealth is $7.00, which is 272.34% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.00 |
| Price Target Difference | 272.34% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 17.34% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on November 14, 2023. It was a reverse split with a ratio of 0.1:1.
| Last Split Date | Nov 14, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.1:1 |
Scores
MDxHealth has an Altman Z-Score of -2.69 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.69 |
| Piotroski F-Score | 3 |